For example, HA-1A may improve outcomes in patients with gram-negative infections and anti-TNF-α therapies may effectively treat patients with elevated IL-6 levels despite these individual therapies' inability to treat all-comers with sepsis. The gene discussed is IL6; the disease is Sepsis.